These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 8906025

  • 1. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ.
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [Abstract] [Full Text] [Related]

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 3. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 4. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

  • 5. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT.
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [Abstract] [Full Text] [Related]

  • 6. Chemoreduction for unilateral retinoblastoma.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [Abstract] [Full Text] [Related]

  • 7. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
    Greenwald MJ, Strauss LC.
    Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
    [Abstract] [Full Text] [Related]

  • 8. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 9. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 10. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 11. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M.
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [Abstract] [Full Text] [Related]

  • 12. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 13. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 14. Current treatment of retinoblastoma.
    De Potter P.
    Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
    [Abstract] [Full Text] [Related]

  • 15. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W, Pietrys D, Romanowska-Dixon B, Kobylarz J, Pawińska-Wasikowska K, Moryl-Bujakowska A.
    Przegl Lek; 2010 Oct; 67(6):404-8. PubMed ID: 21344770
    [Abstract] [Full Text] [Related]

  • 16. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA.
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [Abstract] [Full Text] [Related]

  • 17. Chemoreduction in the initial management of intraocular retinoblastoma.
    Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM.
    Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
    [Abstract] [Full Text] [Related]

  • 18. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 19. [Retinoblastoma update--therapy (Part II)].
    Pogrzebielski A, Shields CL, Romanowska-Dixon B, Shields JA.
    Klin Oczna; 2006 Nov; 108(4-6):258-62. PubMed ID: 17020008
    [Abstract] [Full Text] [Related]

  • 20. Practical approach to management of retinoblastoma.
    Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA.
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.